Clinical Pharmacology Details


DOPAMINE HCL


View Drug Forms

Indications & Dose:

Cardiogenic shock in infarction or cardiac surgery 



Adult: Initially 2–5 micrograms/kg/minute

Contraindications:

Pheochromocytoma, uncorrected tachydysrhythmia or ventricular fibrillation

Side Effects:

CNS: Headache
CV: Aberrant conduction, anginal pain, bradycardia, ectopic beats, hypertension, palpitation, tachycardia, vasoconstriction, widened QRS complex


EENT: Dilated pupils (high doses)
GI: Nausea, vomiting
GU: Azotemia
RESP: Dyspnea 
SKIN: Gangrene (high doses for prolonged periods of time), necrosis, piloerection, tissue sloughing with extravasation

Cautions:

Precautions:

Hypovolemia, arterial embolism, occlusive vascular disease, abrupt discontinuation, sulfite sensitivity, concurrent use of MAOIs


PREGNANCY; because dopamine is indicated only in life threatening situations, chronic use would not be expected; no data available regarding use in breast feeding

Interaction:

Drugs


Ergot alkaloids: Gangrene has been reported
Phenytoin: Increased risk of hypotension with IV phenytoin administration

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: